How Hers launches a microdose plan by answering a skeptical comment | Fluid
Esc

How Hers launches a microdose plan by answering a skeptical comment

An actor-portrayed Hers video in comment-reply format, answering “Aren't you too skinny to be on a GLP-1?” She describes wanting to lose a little weight, an insurance dead end and a low-dose Wegovy pill plan with a $39 first month of membership. The copy says microdosing is off-label and lower doses are unstudied, linking to the Wegovy consultation page.

Hers
53 creatives lead here1 / 53
Hers · Wegovy consultation

Captured while scrolling the public page. Opening prompts are shown without answering health questions. A browser shopping-extension badge may appear in the right margin.

Hers: full page screenshot

A gentler start

The ad introduces a microdose pill plan through a “gentler start” message and states that microdosing is off-label with lower doses unstudied for weight loss. The CTA points to the same Wegovy entry URL as other medication-format ads. Compare the creative with the destination and explore the other ads sharing this route.

Brand
Hers
Observed offer
Membership $39 first month, then $149/mo; medication price not stated
Creative angle
Product launch
Page type
Consultation entry
Ad format
Video · 0:33
Listed start date
Oct 12, 2026
Captured
Oct 20, 2026
Library ID
1354626743215752
Destination
forhers.com

Selected for its design and offer structure. Ad performance isn’t available in this collection.

What this ad does well

The comment-reply format puts the objection on screen before the ad says anything, and answering a skeptic makes the video feel like a conversation rather than a pitch. It speaks to a new audience, people with less weight to lose, and names their situation plainly (struggling to get there on their own, told insurance wouldn't cover it). She ends by addressing anyone who wants just a little extra support, which keeps the ask modest and matches the gentler-start link headline. The ad closes on the real intake screens, including a question about which medication you're interested in, so the next step is visible.

What's missing

The video gives the $39 first month but not the medication price, and the on-screen fine print saying medication is separate goes by quickly. The copy's own disclosure that microdosing is off-label and lower doses may be less effective is important context, and it isn't in the video at all. If you make one like this, put the full cost (membership plus medication) on screen, and keep the most important qualifier in the video itself rather than only in the caption, so viewers decide with the same facts the copy gives.

Beat by beat

  1. 0-3s
    A woman on a velvet chair points at a reply bubble with the comment asking if she's too skinny to be on a GLP-1, labeled actor portrayal.

    It surfaces the skeptic's question first, which earns attention and sets up her answer.

  2. 3-12s
    She says she wanted to lose a little weight, struggled on her own, and her doctor said insurance probably wouldn't cover GLP-1 support.

    It names the audience's situation and the barrier they've already hit.

  3. 12-25s
    She says she saw an ad for the Wegovy pill microdosing plan, got a low dose prescribed, and her first month of membership was $39, with fine print that medication is separate.

    It introduces the new plan as her solution and states the entry price with its condition.

  4. 25s-end
    She lists no needles, insurance or in-person visits, calls it an easy addition to her routine, and invites viewers to take the online assessment as the intake screens appear.

    It removes barriers, keeps the ask small and shows the first step.

The offer

A $39 first month of membership, then $149/month, with medication cost separate and unstated, if prescribed.

Where it sends people

The ad lands on the Hers Wegovy consultation page, a quiz-style entry with a format question in the hero card. The page's dosing-schedule section, about easing in with example monthly dose steps, is a natural continuation of the gentler-start promise, but it sits well below the options carousel and membership section. The FAQ covers cost, insurance and side effects. Nothing near the top mentions the microdose plan, so a visitor has to trust the intake to get there. One of 53 ads in the Fluid library that land on this page.

The page it sends people to: How Hers starts its Wegovy consultation inside the page hero

Hers's Wegovy consultation page opens with the first intake question in a card over the hero, then scrolls through medication cards with "from" monthly prices, a results band, membership perks, a dosing schedule and a long FAQ. 53 ads in the Fluid library send people here, including price-led, food-noise, membership-value and creator-story ads.

How the page is built

  1. 01
    Announcement bar and header

    A single line on affordability sits above a logo-only header, so the price question gets a nod before anything else and there's no navigation to wander off into.

  2. 02
    Hero with intake card

    A full-bleed portrait with a descending line-graph overlay frames a centered card that asks whether the visitor already has a treatment in mind, answering "where do I start?" with three one-tap choices.

  3. 03
    Options carousel

    Horizontal medication cards show the product, prescription and availability tags, a "from" monthly price and a safety link, answering "what are my options and what do they cost?" with pricing and eligibility fine print below.

  4. 04
    Results band

    An outdoor photo of two women carries a headline, three check items and a frosted card with a large outcome figure, which is the page's main answer to "what could this look like for me?"

  5. 05
    Membership

    A four-photo collage (provider, app, product, smart scale) sits over five check-row perks, answering "what am I paying the membership for?"

  6. 06
    Health-marker carousel

    Dark cards pair data-visualization illustrations with short benefit claims and footnotes, covering what the page says treatment can involve beyond the scale.

  7. 07
    Dosing schedule

    A chart of example monthly dose increases and a numbered four-step accordion with dose pills explain how treatment eases in, answering "what happens month to month?"

  8. 08
    FAQ

    A long accordion covers membership, cost, options, visits, insurance, HSA, eligibility, switching and side effects, catching the practical objections that are left.

  9. 09
    Footer

    Disclaimers, an app-download card with a QR code, a pharmacy certification badge and a sister-brand card close the page with trust signals and legal detail.

The first fixes we would make

  1. The membership fee is separate from the medication price, and that detail lives in fine print under the carousel. Put the combined monthly cost (medication plus membership) right under each "from" price, so a visitor who came from a price ad sees the number they'll actually pay before they start the intake.
  2. Creator-story ads send people here, but the page has no member stories or reviews to pick up that voice; the results band shows a single outcome figure instead. Add a short strip of member stories (with the same disclaimers Hers uses elsewhere) near the results band, so someone who clicked a creator's documentary finds people like that creator on the page.

Read the full breakdown of this page

Three hooks you could test

  • Call out the habit you're replacing. “Replying to everyone who asked why I'd bother.”
  • Lead with the uncomfortable problem. “Stuck on the same last few pounds for a year?”
  • Show a specific moment of use. “It's one small step in my morning now.”

What to borrow for your brand

  • Answer a real skeptical comment on screen as your hook, so the objection is raised and handled in the first seconds.
  • Build a version of your offer for a smaller, overlooked segment (less to lose, first-timers) and say who it's for in the copy.
  • Keep the key qualifier from your caption on screen in the video too, so the people who never expand the caption still see it.

Transcript

Aren't you too skinny to be on a GOP one? I was looking to lose a little weight, but I was struggling to get there naturally. But when I turn to my doctor for GLP 1 support, He told me my insurance probably wouldn't even cover it. Then I saw an ad for we go be pill microdosing plan. I got prescribed a low dose of the Wego V pill. And the first month of membership was only $39. No needle, insurance or in person doctor business required? It's been an easy addition to my routine. I wish I had found out about it soon. If you're looking for just a little extra support, I suggest taking the online assessment today to start.
Text on screen
  • Reply toJYN's comment
  • Aren't you too skinny to
  • be on a GLP-1?
  • Actor portrayal
  • Reply to JYN's comment
  • but I was struggling to get
  • there naturally.
  • for GLP-1 support,
  • he told me
  • my insurance
  • probably wouldn't
  • even cover it.
  • Then I saw an ad for
  • Wegovy® Pill Microdosing Plan,
  • I got prescribed a low
  • dose of the Wegovy pill,
  • $149/mo thereafter, medication
  • cost is separate.
  • Priso is tudounembership fee only. Membership is biled separately
  • and deconstivalide or guarantee a prescription. Medication is not
  • available without a membership:
  • $149Ymo thereafter, medication
  • Piss ineludeemembership fee only. Membership is briga separately
  • and essentinside or guarantee a prescription. Medicationts not
  • available without a membership.
  • and the first month of Hers
  • membership was only $39P
  • *Price includes membership fee only. Membership is billed separately
  • and does not include or guarantee a prescription. Medication is not
  • avalla ble without a membership.
  • No needles,
  • or in person doctor
  • visits required.
  • It's been an easy
  • addition to my routine
  • I wish I had found out
  • about it sooner.
  • If you're looking for just
  • a little extra support,
  • If youre looking for just

One of 125 Hers ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 20, 2026. We record that an ad ran publicly, not how it performed.